- "Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome"
B.H. Skogman, S. Croner, M. Nordwal, et al.
Pediatric. Infect. Dis. J. 27: 1089-1094, 2008. - "Lyme borreliosis: a European perspective on diagnosis and clinical management"
G. Stanek, and F. Strle
Curr. Opin. Infect. Dis. 2009, June 29, ePub ahead of print. - "Antibiotic treatment of animals infected with Borrelia burgdorferi"
G.P. Wormser, and I. Schwartz
Clin. Microbiol. Rev. 22: 387-395, 2009. - "Lyme disease in pregnancy: case report and review of the literature" C.A. Walsh, E.W. Mayer, and L.V. Baxi
Obstet. Gynecol. Surv. 62: 41-50, 2007. - "Lyme disease serology in amyotrophic lateral sclerosis (ALS)" Qureshi, M., R.S. Bedlock, and M.E. Cudkowicz
Muscle and Nerve 40: 626-628, 2009. Editor’s Note: Since ceftriaxone has been reported to have profound neuroprotective effects (Nature 433: 73-77, 2005) and is often used to treat Lyme disease with neurological complications, clinical studies are in progress to assess its efficacy for the treatment of ALS. - "ALSUntangled update 1: investigating a bug (Lyme disease) and a drug (Iplex) on behalf of people with ALS"
The ALSUntangled Group
Amyotrophic Lateral Sclerosis 10: 248-250, 2009. -
"Antibiotic treatment duration and long-term
outcomes of patients with early Lyme disease from
a Lyme disease- hyperendemic area"
Kowalski, TJ, Tata, S, Mathiason, MA and Agger, WA
Clin. Infect. Dis. 50: 512-520, 2010.
